Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Peter Kabos

Concepts (401)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
52
2025
2132
5.870
 Why?
Receptors, Estrogen
21
2025
424
3.110
 Why?
Receptor, ErbB-2
14
2024
325
2.020
 Why?
Receptors, Progesterone
11
2020
341
1.260
 Why?
Brain Neoplasms
14
2023
1163
1.010
 Why?
Keratin-5
6
2022
49
0.850
 Why?
Triple Negative Breast Neoplasms
6
2023
191
0.830
 Why?
Estrogens
7
2023
342
0.820
 Why?
Breast Neoplasms, Male
3
2018
29
0.790
 Why?
Biomarkers, Tumor
7
2022
1181
0.790
 Why?
Stem Cells
8
2006
578
0.770
 Why?
Antineoplastic Agents, Hormonal
7
2025
158
0.730
 Why?
Tetrahydronaphthalenes
1
2021
29
0.710
 Why?
Estrogen Receptor alpha
4
2024
132
0.710
 Why?
Drug Resistance, Neoplasm
5
2025
749
0.700
 Why?
Neoplasm Metastasis
4
2020
608
0.700
 Why?
Immunoprecipitation
4
2020
157
0.680
 Why?
Neoplastic Cells, Circulating
1
2020
70
0.670
 Why?
Benzodiazepines
1
2021
129
0.670
 Why?
Neurons
8
2004
1448
0.660
 Why?
Radiosurgery
3
2023
318
0.660
 Why?
Brain Edema
2
2023
60
0.650
 Why?
Carcinoma, Intraductal, Noninfiltrating
2
2017
54
0.620
 Why?
Epithelial-Mesenchymal Transition
1
2020
199
0.610
 Why?
Leukocytes, Mononuclear
2
2020
539
0.600
 Why?
Gene Expression Regulation, Neoplastic
11
2025
1351
0.570
 Why?
Gene Expression Profiling
7
2020
1688
0.570
 Why?
Fanconi Anemia Complementation Group N Protein
1
2017
5
0.550
 Why?
Polyadenylation
1
2017
40
0.550
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2024
1559
0.550
 Why?
High-Throughput Nucleotide Sequencing
4
2019
484
0.540
 Why?
Female
54
2025
68154
0.540
 Why?
Organoplatinum Compounds
1
2016
40
0.540
 Why?
Neoplastic Stem Cells
7
2020
386
0.540
 Why?
Carcinogenesis
2
2020
209
0.540
 Why?
Cancer-Associated Fibroblasts
1
2016
13
0.530
 Why?
Fluorouracil
1
2016
197
0.500
 Why?
Artifacts
1
2016
123
0.500
 Why?
CD146 Antigen
3
2021
41
0.490
 Why?
Mitochondrial Proteins
1
2017
244
0.480
 Why?
Thrombocytopenia
1
2016
181
0.470
 Why?
MCF-7 Cells
4
2020
115
0.460
 Why?
Maytansine
1
2014
16
0.460
 Why?
Cell Line, Tumor
15
2025
3184
0.450
 Why?
Humans
67
2025
128418
0.440
 Why?
Analgesics, Opioid
1
2021
887
0.410
 Why?
Trastuzumab
5
2023
100
0.410
 Why?
Binding Sites
1
2016
1236
0.410
 Why?
RNA-Binding Proteins
1
2016
388
0.400
 Why?
Tumor Microenvironment
4
2021
623
0.400
 Why?
Receptors, Cytoplasmic and Nuclear
1
2014
215
0.400
 Why?
Neoplasms, Hormone-Dependent
1
2012
38
0.400
 Why?
Antineoplastic Agents
4
2023
2051
0.390
 Why?
Tamoxifen
5
2025
200
0.390
 Why?
Homeodomain Proteins
5
2018
490
0.380
 Why?
Piperazines
2
2024
336
0.370
 Why?
Neoplasm Recurrence, Local
5
2021
958
0.370
 Why?
MicroRNAs
5
2016
677
0.370
 Why?
Chemotherapy, Adjuvant
5
2023
376
0.370
 Why?
Protein Kinase Inhibitors
5
2021
872
0.360
 Why?
RNA
2
2016
880
0.360
 Why?
Estradiol
3
2015
486
0.360
 Why?
Neoadjuvant Therapy
3
2021
381
0.350
 Why?
Mutation
3
2021
3689
0.350
 Why?
Antibodies, Monoclonal, Humanized
2
2021
755
0.340
 Why?
Liver Neoplasms
1
2015
633
0.340
 Why?
Pyridines
2
2024
475
0.340
 Why?
Progestins
5
2020
78
0.340
 Why?
Pyrimidines
3
2018
445
0.320
 Why?
Colorectal Neoplasms
1
2016
746
0.320
 Why?
Tumor Cells, Cultured
7
2020
930
0.320
 Why?
Prognosis
7
2021
3772
0.310
 Why?
Carcinoma, Ductal, Breast
2
2020
82
0.310
 Why?
Adenocarcinoma
1
2015
888
0.300
 Why?
Hydrocephalus
3
2023
108
0.300
 Why?
Bone Marrow Cells
2
2014
294
0.290
 Why?
Signal Transduction
5
2018
4826
0.280
 Why?
Middle Aged
16
2024
30889
0.280
 Why?
Neoplasm Staging
4
2021
1290
0.270
 Why?
Astrocytes
5
2023
188
0.270
 Why?
Helix-Loop-Helix Motifs
2
2002
12
0.260
 Why?
Necrosis
2
2019
229
0.250
 Why?
Cluster Analysis
4
2019
478
0.250
 Why?
Chondroitin Sulfate Proteoglycans
2
2006
10
0.250
 Why?
Sequence Analysis, RNA
2
2019
429
0.240
 Why?
Fatty Acid Synthase, Type I
1
2025
11
0.240
 Why?
Neuroglia
2
2003
166
0.240
 Why?
Neoplasm Grading
2
2017
283
0.230
 Why?
Aged
14
2024
21953
0.230
 Why?
Genetic Therapy
2
2003
290
0.230
 Why?
Mice, Inbred NOD
5
2021
586
0.230
 Why?
Aromatase Inhibitors
2
2021
51
0.230
 Why?
Disease-Free Survival
4
2024
647
0.220
 Why?
Carbolines
1
2024
27
0.220
 Why?
Triazines
1
2024
38
0.220
 Why?
Adult
16
2024
35300
0.220
 Why?
Animals
27
2021
34479
0.220
 Why?
Progesterone
3
2014
242
0.220
 Why?
Morpholines
1
2024
122
0.210
 Why?
Extracellular Matrix Proteins
1
2004
140
0.210
 Why?
Mice
19
2021
16602
0.210
 Why?
Glioma
5
2006
353
0.210
 Why?
Keratin-17
1
2022
4
0.200
 Why?
Aquaporin 4
2
2023
96
0.200
 Why?
Nerve Regeneration
1
2002
62
0.200
 Why?
Stromal Cells
2
2020
105
0.200
 Why?
Triglycerides
1
2025
523
0.200
 Why?
Mice, SCID
4
2020
350
0.200
 Why?
Tumor Suppressor Proteins
2
2015
313
0.200
 Why?
Immunoconjugates
1
2023
101
0.200
 Why?
Down-Regulation
4
2015
631
0.200
 Why?
Cell-Free Nucleic Acids
1
2022
31
0.190
 Why?
Neoplasm Invasiveness
3
2020
480
0.190
 Why?
Interleukin-13 Receptor alpha2 Subunit
1
2021
5
0.190
 Why?
Medicare
3
2023
715
0.190
 Why?
Lipid Metabolism
1
2025
491
0.190
 Why?
Cyclins
1
2002
85
0.190
 Why?
Aged, 80 and over
4
2024
7033
0.180
 Why?
Tumor Suppressor Protein p53
2
2015
508
0.180
 Why?
Gene Regulatory Networks
2
2014
280
0.180
 Why?
gamma-Aminobutyric Acid
1
2002
158
0.180
 Why?
Insulin Receptor Substrate Proteins
1
2020
59
0.180
 Why?
Cell Adhesion Molecules
1
2021
172
0.180
 Why?
RNA, Messenger
3
2019
2675
0.180
 Why?
Cancer Care Facilities
1
2020
32
0.170
 Why?
Meningeal Carcinomatosis
1
2020
8
0.170
 Why?
Hyaluronan Receptors
4
2014
97
0.170
 Why?
Antineoplastic Agents, Immunological
2
2019
175
0.170
 Why?
SEER Program
1
2021
206
0.170
 Why?
Carcinoma, Lobular
1
2020
48
0.170
 Why?
Cell Proliferation
6
2025
2344
0.170
 Why?
Transcriptome
2
2019
881
0.170
 Why?
Aminopyridines
1
2020
96
0.170
 Why?
Gene Library
2
2019
115
0.170
 Why?
Collagen
2
2020
429
0.160
 Why?
Repressor Proteins
1
2002
399
0.160
 Why?
Retrospective Studies
5
2023
14454
0.160
 Why?
Lymphatic Metastasis
2
2017
318
0.160
 Why?
Benzimidazoles
1
2020
157
0.160
 Why?
Antigens, Neoplasm
1
2021
309
0.160
 Why?
ErbB Receptors
2
2020
601
0.160
 Why?
Paclitaxel
1
2020
214
0.150
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
52
0.150
 Why?
beta Catenin
1
2020
219
0.150
 Why?
Xenograft Model Antitumor Assays
4
2017
814
0.140
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2017
81
0.140
 Why?
Heterografts
4
2020
129
0.140
 Why?
Treatment Outcome
5
2023
10152
0.140
 Why?
RNA Polymerase III
1
2017
26
0.140
 Why?
Disease Progression
4
2018
2602
0.140
 Why?
3' Untranslated Regions
1
2017
140
0.130
 Why?
Pyrroles
1
2017
191
0.130
 Why?
Neoplasms, Radiation-Induced
1
2016
71
0.130
 Why?
Genital Neoplasms, Female
1
2017
81
0.130
 Why?
Single-Cell Analysis
1
2019
272
0.130
 Why?
Receptors, Androgen
1
2017
143
0.130
 Why?
Gene Expression
2
2016
1456
0.120
 Why?
Ovary
1
2017
210
0.120
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
940
0.120
 Why?
Ribosomal Proteins
1
2015
77
0.120
 Why?
Combined Modality Therapy
2
2019
1204
0.120
 Why?
Neoplasms, Second Primary
1
2016
108
0.120
 Why?
Proto-Oncogene Proteins c-akt
1
2017
421
0.120
 Why?
Paracrine Communication
1
2015
60
0.120
 Why?
DNA Primers
1
2016
510
0.120
 Why?
Risk Reduction Behavior
1
2016
209
0.120
 Why?
Pyrazoles
1
2018
404
0.120
 Why?
Hodgkin Disease
1
2016
134
0.120
 Why?
Fibroblasts
1
2020
935
0.120
 Why?
Reactive Oxygen Species
1
2017
577
0.120
 Why?
Obesity
2
2018
2858
0.120
 Why?
Azepines
1
2015
88
0.120
 Why?
STAT5 Transcription Factor
1
2014
48
0.110
 Why?
Peptides
1
2020
908
0.110
 Why?
Odds Ratio
1
2017
1023
0.110
 Why?
Clinical Decision-Making
1
2017
304
0.110
 Why?
Receptors, Steroid
1
2014
48
0.110
 Why?
Apoptosis
4
2017
2435
0.110
 Why?
Opioid-Related Disorders
1
2021
480
0.110
 Why?
Disease Models, Animal
4
2017
3937
0.100
 Why?
Sensitivity and Specificity
2
2016
1815
0.100
 Why?
DNA-Binding Proteins
2
2015
1421
0.100
 Why?
CD24 Antigen
1
2012
20
0.100
 Why?
RNA Interference
1
2014
441
0.100
 Why?
Retinoids
1
2012
34
0.100
 Why?
Anthracyclines
2
2023
46
0.100
 Why?
Cell Differentiation
4
2004
1900
0.100
 Why?
Clinical Trials as Topic
1
2017
993
0.100
 Why?
Comorbidity
1
2017
1543
0.100
 Why?
Taxoids
2
2023
95
0.100
 Why?
Male
8
2018
62858
0.100
 Why?
Doxorubicin
3
2022
322
0.100
 Why?
United States
4
2023
13830
0.090
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2012
163
0.090
 Why?
Small Molecule Libraries
1
2012
86
0.090
 Why?
Genome, Human
1
2014
391
0.090
 Why?
Rats
5
2017
5165
0.090
 Why?
Mitochondria
1
2017
848
0.090
 Why?
Drug Discovery
1
2012
130
0.090
 Why?
Tumor Burden
1
2012
283
0.090
 Why?
Logistic Models
1
2016
1974
0.090
 Why?
Basic Helix-Loop-Helix Transcription Factors
2
2002
230
0.090
 Why?
Time Factors
3
2020
6482
0.090
 Why?
Lung Neoplasms
1
2023
2328
0.090
 Why?
Nuclear Proteins
1
2015
657
0.080
 Why?
Oligonucleotide Array Sequence Analysis
1
2012
756
0.080
 Why?
Dendritic Cells
2
2004
479
0.080
 Why?
Estrogen Antagonists
1
2010
45
0.080
 Why?
Protein Binding
1
2016
2103
0.080
 Why?
Transforming Growth Factor beta
1
2012
445
0.080
 Why?
Administration, Oral
2
2024
754
0.080
 Why?
BRCA2 Protein
1
2009
53
0.080
 Why?
Cell Culture Techniques
2
2020
345
0.080
 Why?
Thrombophilia
1
2009
66
0.080
 Why?
Pregnancy Complications, Neoplastic
1
2009
52
0.080
 Why?
Receptors, CXCR4
2
2006
82
0.080
 Why?
Quinolines
2
2021
153
0.080
 Why?
Practice Patterns, Physicians'
1
2017
1258
0.080
 Why?
Cells, Cultured
3
2006
4001
0.070
 Why?
Cell Movement
3
2015
936
0.070
 Why?
Brain
2
2023
2620
0.070
 Why?
Tumor Necrosis Factor-alpha
2
2002
1185
0.070
 Why?
Stem Cell Transplantation
3
2004
165
0.070
 Why?
Rats, Sprague-Dawley
2
2002
2239
0.070
 Why?
Genetic Predisposition to Disease
1
2016
2264
0.070
 Why?
Proteoglycans
2
2006
109
0.070
 Why?
Radiotherapy, Adjuvant
2
2018
209
0.070
 Why?
Risk Factors
2
2020
9704
0.070
 Why?
Drug Delivery Systems
1
2010
325
0.070
 Why?
Immunohistochemistry
2
2017
1664
0.070
 Why?
Aurora Kinase A
2
2018
55
0.070
 Why?
Severity of Illness Index
1
2014
2722
0.060
 Why?
Biopsy
2
2020
1081
0.060
 Why?
Nervous System
1
2006
66
0.060
 Why?
Rats, Inbred F344
2
2003
251
0.060
 Why?
Tomography, X-Ray Computed
1
2015
2523
0.060
 Why?
Mass Spectrometry
2
2020
659
0.060
 Why?
Neoplasm Transplantation
2
2016
258
0.060
 Why?
Infant, Premature, Diseases
1
2006
93
0.060
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 5
1
2004
1
0.060
 Why?
Aggrecans
1
2004
14
0.060
 Why?
Lectins, C-Type
1
2004
64
0.060
 Why?
Isoquinolines
1
2024
41
0.060
 Why?
Azetidines
1
2024
40
0.060
 Why?
Cyclophosphamide
2
2018
227
0.060
 Why?
Maximum Tolerated Dose
1
2024
192
0.050
 Why?
Adipose Tissue
2
2018
589
0.050
 Why?
Cell Line
2
2014
2731
0.050
 Why?
Hemangioma, Cavernous, Central Nervous System
1
2003
6
0.050
 Why?
Mastectomy, Segmental
2
2017
85
0.050
 Why?
Glioblastoma
2
2006
322
0.050
 Why?
Mice, Inbred C57BL
5
2004
5272
0.050
 Why?
Aromatase
1
2023
31
0.050
 Why?
Inhibitor of Differentiation Protein 1
1
2002
6
0.050
 Why?
Inhibitor of Differentiation Protein 2
1
2002
5
0.050
 Why?
Camptothecin
1
2023
106
0.050
 Why?
Neoplasms, Multiple Primary
1
2003
54
0.050
 Why?
Edema
1
2023
125
0.050
 Why?
Pyramidal Tracts
1
2002
26
0.050
 Why?
Hepatocyte Nuclear Factor 3-alpha
1
2022
8
0.050
 Why?
Neurites
1
2002
46
0.050
 Why?
Sciatic Nerve
1
2002
60
0.050
 Why?
Gonadotropin-Releasing Hormone
1
2024
207
0.050
 Why?
Transcription Factor HES-1
1
2002
5
0.050
 Why?
Vimentin
1
2022
50
0.050
 Why?
Interleukin-12
1
2002
119
0.050
 Why?
Phenotype
1
2010
3044
0.050
 Why?
Blotting, Western
1
2004
1164
0.050
 Why?
Frontal Lobe
1
2002
153
0.050
 Why?
Oligonucleotides, Antisense
1
2002
106
0.050
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2002
114
0.050
 Why?
Fibroblast Growth Factors
1
2002
170
0.050
 Why?
Mice, Inbred BALB C
1
2004
1228
0.050
 Why?
TOR Serine-Threonine Kinases
1
2024
380
0.050
 Why?
Ependymoma
1
2003
176
0.050
 Why?
Neoplasms
1
2015
2464
0.050
 Why?
Protein-Lysine 6-Oxidase
1
2020
8
0.050
 Why?
Cerebral Cortex
1
2004
423
0.040
 Why?
Nucleosomes
1
2022
137
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2020
50
0.040
 Why?
Hospitals, University
1
2021
176
0.040
 Why?
Nervous System Diseases
1
2003
252
0.040
 Why?
Animals, Newborn
1
2002
803
0.040
 Why?
Membrane Glycoproteins
1
2002
466
0.040
 Why?
Adherens Junctions
1
2020
26
0.040
 Why?
Dose-Response Relationship, Drug
1
2024
1936
0.040
 Why?
Gene Knockout Techniques
1
2020
109
0.040
 Why?
Protein Interaction Mapping
1
2020
107
0.040
 Why?
Kaplan-Meier Estimate
1
2021
853
0.040
 Why?
Interferon-gamma
1
2002
759
0.040
 Why?
Mice, Nude
2
2015
682
0.040
 Why?
DNA, Complementary
1
2019
267
0.040
 Why?
beta-Galactosidase
3
2002
75
0.040
 Why?
Loss of Function Mutation
1
2018
39
0.040
 Why?
Immunotherapy
1
2003
587
0.040
 Why?
Maintenance Chemotherapy
1
2018
22
0.040
 Why?
Cadherins
1
2020
186
0.040
 Why?
Wnt Signaling Pathway
1
2020
165
0.040
 Why?
Nausea
1
2018
107
0.040
 Why?
Promoter Regions, Genetic
2
2012
1198
0.040
 Why?
Breast
1
2018
152
0.040
 Why?
Mastectomy
1
2018
131
0.030
 Why?
Phenylthiohydantoin
1
2017
44
0.030
 Why?
Diarrhea
1
2018
177
0.030
 Why?
Antigens, CD
1
2020
482
0.030
 Why?
Mammary Neoplasms, Experimental
1
2017
66
0.030
 Why?
Area Under Curve
1
2017
279
0.030
 Why?
Ovariectomy
1
2017
136
0.030
 Why?
Nitriles
1
2017
157
0.030
 Why?
Steroids
1
2017
147
0.030
 Why?
Benzamides
1
2017
194
0.030
 Why?
Fatigue
1
2018
317
0.030
 Why?
Cell Membrane
1
2020
720
0.030
 Why?
Flow Cytometry
2
2012
1142
0.030
 Why?
Apoptosis Regulatory Proteins
2
2009
182
0.030
 Why?
Chromatography, Liquid
1
2017
374
0.030
 Why?
Proto-Oncogene Proteins c-mdm2
1
2015
63
0.030
 Why?
Postmenopause
1
2017
348
0.030
 Why?
Tumor Protein p73
1
2015
14
0.030
 Why?
Transcription Factors
1
2002
1628
0.030
 Why?
Weight Gain
1
2018
503
0.030
 Why?
Gene Knockdown Techniques
1
2015
312
0.030
 Why?
Molecular Targeted Therapy
1
2017
385
0.030
 Why?
Jagged-1 Protein
1
2014
22
0.030
 Why?
Serrate-Jagged Proteins
1
2014
27
0.030
 Why?
Argonaute Proteins
1
2014
28
0.030
 Why?
Wnt-5a Protein
1
2014
21
0.030
 Why?
Software
1
2019
608
0.030
 Why?
Matrix Metalloproteinase 2
1
2014
55
0.030
 Why?
Testosterone
1
2017
373
0.030
 Why?
Transcription, Genetic
1
2020
1404
0.030
 Why?
Cellular Microenvironment
1
2014
80
0.030
 Why?
Interleukin-6
1
2017
716
0.030
 Why?
Cell Transformation, Neoplastic
1
2015
325
0.030
 Why?
Wnt Proteins
1
2014
126
0.030
 Why?
Guideline Adherence
1
2017
521
0.030
 Why?
Gene Expression Regulation
1
2022
2505
0.030
 Why?
Socioeconomic Factors
1
2017
1212
0.030
 Why?
Acitretin
1
2012
3
0.030
 Why?
Miconazole
1
2012
5
0.030
 Why?
Calcium-Binding Proteins
1
2014
210
0.030
 Why?
Isotretinoin
1
2012
23
0.020
 Why?
Intercellular Signaling Peptides and Proteins
1
2014
371
0.020
 Why?
Luciferases
1
2012
147
0.020
 Why?
Genes, Reporter
1
2012
265
0.020
 Why?
Biomarkers
2
2017
3880
0.020
 Why?
Tretinoin
1
2012
128
0.020
 Why?
Magnetic Resonance Imaging
2
2019
3376
0.020
 Why?
Vascular Endothelial Growth Factor A
1
2014
500
0.020
 Why?
Risk Assessment
1
2020
3232
0.020
 Why?
Green Fluorescent Proteins
1
2012
380
0.020
 Why?
Follow-Up Studies
1
2020
4892
0.020
 Why?
Diet
1
2018
1199
0.020
 Why?
Colorado
1
2020
4375
0.020
 Why?
Proto-Oncogene Proteins
1
2014
634
0.020
 Why?
Base Sequence
1
2014
2135
0.020
 Why?
HEK293 Cells
1
2012
683
0.020
 Why?
Age Factors
1
2017
3103
0.020
 Why?
Practice Guidelines as Topic
1
2017
1478
0.020
 Why?
Pregnancy Trimester, Second
1
2009
78
0.020
 Why?
Molecular Sequence Data
1
2014
2819
0.020
 Why?
Hypertension
1
2018
1235
0.020
 Why?
Pregnancy Trimester, First
1
2009
138
0.020
 Why?
Endothelial Cells
1
2014
698
0.020
 Why?
Lymph Node Excision
1
2009
165
0.020
 Why?
Transplantation, Heterologous
1
2008
187
0.020
 Why?
Membrane Proteins
1
2014
1105
0.020
 Why?
Neoplasms, Experimental
1
2008
169
0.020
 Why?
CD8-Positive T-Lymphocytes
2
2002
846
0.020
 Why?
Infant, Newborn
2
2009
5687
0.020
 Why?
CD4-Positive T-Lymphocytes
2
2002
1046
0.020
 Why?
Chemokines, CXC
1
2006
68
0.020
 Why?
Nestin
1
2006
19
0.020
 Why?
Laminin
1
2006
68
0.020
 Why?
Intermediate Filament Proteins
1
2006
57
0.020
 Why?
Chemokine CXCL12
1
2006
77
0.020
 Why?
Glial Fibrillary Acidic Protein
1
2006
92
0.020
 Why?
Lasers
1
2006
132
0.020
 Why?
Drug Combinations
1
2006
323
0.010
 Why?
Adolescent
1
2024
20179
0.010
 Why?
Culture Media, Conditioned
1
2004
108
0.010
 Why?
RNA, Small Interfering
1
2006
571
0.010
 Why?
Injections, Intralesional
1
2003
34
0.010
 Why?
TNF-Related Apoptosis-Inducing Ligand
1
2002
43
0.010
 Why?
3T3 Cells
1
2002
151
0.010
 Why?
Random Allocation
1
2003
343
0.010
 Why?
Nerve Tissue Proteins
1
2006
567
0.010
 Why?
Models, Neurological
1
2004
236
0.010
 Why?
Adenoviridae
1
2002
189
0.010
 Why?
Infant, Premature
1
2006
535
0.010
 Why?
Reference Values
1
2003
776
0.010
 Why?
Genetic Vectors
1
2002
311
0.010
 Why?
Oligodendroglia
1
2002
166
0.010
 Why?
Transfection
1
2002
893
0.010
 Why?
Recombinant Fusion Proteins
1
2002
634
0.010
 Why?
Survival Rate
1
2003
1869
0.010
 Why?
Case-Control Studies
1
2006
3328
0.010
 Why?
Pregnancy
1
2009
6357
0.010
 Why?
Vaccination
1
2003
1346
0.010
 Why?
Prospective Studies
1
2006
7036
0.010
 Why?
Infant
1
2006
8914
0.010
 Why?
Kabos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (401) concept(s)
_
Co-Authors Expand Description
See all (68) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)